This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Series
Menu

Masahito Sato
Astellas Pharma, Inc. at Astellas Pharma, Inc.
Speaker

Profile

I am currently a Senior Researcher of Astellas Pharma Inc. and leading an immuno-oncology project.

Before joining Astellas, I participated in discovery of cancer therapeutic antibody drugs at MEDICAL & BIOLOGICAL LABORATORIES (MBL) using a phage display system. Since 2011, I have generated various antibodies for the acute disease patients as well as for the cancer patients in Astellas. I have 12 years of experience in engineering of antibodies such as bispecific antibodies and protein fusion antibodies.


At this event

Prev
Next
Aaron Sato, PhD
Chief Scientific Officer
LakePharma, Inc.

See Masahito at Antibody Engineering & Therapeutics Series